Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. Total Liabilities 2018–2025
Cue Biopharma, Inc. annual total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cue Biopharma, Inc. total liabilities as of December 31, 2025: 15.8M, a 7.41% increase year-over-year.
- Cue Biopharma, Inc. total liabilities for 2025 were 15.8M, a 7.41% increase from 2024.
- Cue Biopharma, Inc. total liabilities for 2024 were 14.7M, a 39.90% decrease from 2023.
- Cue Biopharma, Inc. total liabilities for 2023 were 24.4M, a 4.52% decrease from 2022.
- Cue Biopharma, Inc. total liabilities for 2022 were 25.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cue Biopharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $16 |
| 2024 | $15 |
| 2023 | $24 |
| 2022 | $26 |
| 2021 | $18 |
| 2020 | $21 |
| 2019 | $17 |
| 2018 | $11 |
Cue Biopharma, Inc. Total Liabilities — FAQ
Cue Biopharma, Inc. (CUE) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CUE's total liabilities history?
The chart and table above show Cue Biopharma, Inc.'s total liabilities by year and by quarter, including the growth rate.